In conclusion, given that a woman experienced a recurrence after a primary DCIS, tumor markers related to a recurrence being invasive compared to a new in situ were ER+, HER2−, and EGFR−. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.